tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market
RCUS
Arcus Biosciences
RESEARCH TOOLSreports

Arcus Biosciences (RCUS) Stock News & Sentiment

Compare
539 Followers
Arcus Biosciences Announces COO Resignation and Transition Plan
Premium
Company Announcements
Arcus Biosciences Announces COO Resignation and Transition Plan
23h ago
8K
RCUS
Arcus Biosciences: Casdatifan’s Differentiated HIF-2α Profile Versus Belzutifan Supports High-Risk Buy Rating
Premium
Ratings
Arcus Biosciences: Casdatifan’s Differentiated HIF-2α Profile Versus Belzutifan Supports High-Risk Buy Rating
22d ago
RCUS
Arcus Biosciences Highlights Casdatifan Momentum in Call
Premium
Company Announcements
Arcus Biosciences Highlights Casdatifan Momentum in Call
23d ago
RCUS
Buy Rating on Arcus Biosciences Driven by Best-in-Class Casdatifan Data in Renal Cell Carcinoma and Favorable Phase 3 Risk‑Reward
Premium
Ratings
Buy Rating on Arcus Biosciences Driven by Best-in-Class Casdatifan Data in Renal Cell Carcinoma and Favorable Phase 3 Risk‑Reward
28d ago
RCUS
Arcus’s Lead HIF-2α Inhibitor Delivers Superior Late-Line RCC Efficacy, De-Risking PEAK-1 and Supporting Buy Rating
Premium
Ratings
Arcus’s Lead HIF-2α Inhibitor Delivers Superior Late-Line RCC Efficacy, De-Risking PEAK-1 and Supporting Buy Rating
28d ago
RCUS
Arcus Biosciences (RCUS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Arcus Biosciences (RCUS) Q4 Earnings Cheat Sheet
29d ago
RCUS
Arcus Advances Quemliclustat With New Phase 1 Study: What Investors Should Know
Premium
Company Announcements
Arcus Advances Quemliclustat With New Phase 1 Study: What Investors Should Know
1M ago
RCUS
More RCUS News >

RCUS News on the Web

Arcus Biosciences Announces COO Resignation and Transition Plan
TipRanks News
Neutral
Damora Therapeutics appoints Jennifer Jarrett as CEO
TipRanks News
Neutral
Citigroup Raises Arcus Biosciences (RCUS) Price Target to $45 | RCUS Stock News
GuruFocus News
Bullish
Arcus Biosciences price target raised to $45 from $44 at Citi
TipRanks News
Bullish
Evercore ISI Sticks to Their Buy Rating for Arcus Biosciences (RCUS)
TipRanks News
Neutral
RCUS Analyst Rating Updated by Leerink Partners | RCUS Stock News
GuruFocus News
Neutral
Wedbush Keeps Their Buy Rating on Arcus Biosciences (RCUS)
TipRanks News
Neutral
Why Arcus Biosciences Stock Is Surging Today
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
RCUS
Sector Average
Media Buzz
This Week2 articles
Weekly Average6 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RCUS’s Media Buzz Sentiment?
2 articles about RCUS were published this week. In an average week, 6 articles are published.
    What is RCUS’s weekly average amount of articles?
    In an average week, 6 articles about RCUS are published.
      What is RCUS’s News Sentiment?
      50% of articles about RCUS were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        HYPRHyperfine
        OVIDOvid Therapeutics
        INNMFAmplia Therapeutics
        ALMSAlumis Inc.
        NWPHFNewron Pharmaceuticals SpA
        Showing the stocks with the most bullish news sentiment over the past week